drug discovery company
Welcome to Avian, where scientific innovation meets medical excellence. We strive to develop groundbreaking drug molecules for various disorders, setting new standards in targeted drug delivery.
About Us
Founded in 2022, Avian Pharma Company is a visionary pharmaceutical startup dedicated to advancing healthcare. Specializing in gastrointestinal, neurological, skin, cancer and cardiovascular drugs, our mission is to accelerate the drug development and ensure precise treatment delivery.
Innovative Biotech
%20(2).jpg)
Advancing Medicine
Avian Pharma Company is dedicated to revolutionizing biotechnology to combat diseases like cancer. Our cutting-edge research and development focus on creating advanced therapies and medications to improve patient outcomes. With a team of skilled scientists and researchers, we strive to push the boundaries of science and technology. At Avian Pharma Company, we are committed to making a difference in the field of biotechnology and contributing to the advancement of medicine for a healthier future. In addition, our company is focusing to develop a thermoregulated and compress/collapsible transparent suit to meet the requirements and suitability in Emergency care setting.
About
Who We Are
SARJ LLC ,DBA AVIAN PHARMA COMPANY is a startup pharmaceutical company, based in Maryland, USA. The people working for our company are a team of researchers from various backgrounds. The founder and owner of the company is Dr.Suresh Reddy Jannapally, Rph, Phd. He has done master’s in pharmacology and PhD in colloidal drug delivery system. He has been working as a community pharmacist for the past 17 years and his interest in drug discovery motivated to start the company. His experience helped him to learn the areas where there is scope for advancement. The objective of the company is to find the solutions for the unmet needs of healthcare community. Our team has extensive knowledge in the areas of cancer, cardiovascular diseases, neurological disorders, skin disorders and wound healing.
Focus of research
cancer treatment
inflammatory bowel disorders
cardiovascular disorders
neurological disorders
Lead Molecules in development
Team
Dr.Suresh Reddy Jannapally, Rph, PhD(owner)
Dr. Jayant Vodela, DVM
Dr. Venkateswarlu Vobalaboina, PhD
Dr.Srinivas Chennamaneni, PhD
Dr. Chidananda Swamy, PhD
Prudvi Pedaveeti, Rph
Sindhu Pedaveeti, MS
Satish Reddy Musku, Rph
Sharath Ponnamaneni,CA
Swathi Pedaveeti, BCA(Co-owner)
​
​
our company is trying to obtain the support for research activities and operations from funding agencies.